Literature DB >> 8465014

Neutron capture imaging of 10B in tissue specimens.

C P Ceberg1, L G Salford, A Brun, R J Hemler, B R Persson.   

Abstract

Boron Neutron Capture Therapy (BNCT) is an attractive concept for radiation treatment of malignant tumours. The patients receive a 10B-carrying compound with selective uptake in tumour cells, after which they are irradiated with epithermal neutrons. Theoretically, the tumour cells are killed by the high-LET particles produces in 10B(n, alpha)7Li reactions inside or close to the cell nucleus, while healthy brain cells with no boron uptake will be spared. In practice, a successful BNCT depends on the actual boron-distribution in the tissue, and consequently a new boron-compound aimed for BNCT must undergo detailed bio-distribution studies before clinical trials. In experimental work there is accordingly a great need for methods for quantitative bio-distribution measurements in tissue samples. In this paper we present an improved technique for neutron activated autoradiography providing quantitative boron images of freeze-sectioned tissue specimens from highly malignant rat brain gliomas. Particular attention has been paid to the correlation with the morphology of the specimens and to the altered self-absorption properties due to freeze-drying. A self-absorption correction factor for tumour tissue has been experimentally determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465014     DOI: 10.1016/0167-8140(93)90095-p

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Development of a simple and rapid method of precisely identifying the position of 10B atoms in tissue: an improvement in standard alpha autoradiography.

Authors:  Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Shin-ichiro Masunaga; Koichi Takamiya; Akira Maruhashi; Koji Ono
Journal:  J Radiat Res       Date:  2013-10-18       Impact factor: 2.724

2.  The RG2 rat glioma model.

Authors:  A T Aas; A Brun; C Blennow; S Strömblad; L G Salford
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.